Search results
Results from the WOW.Com Content Network
An "incident" of chemical food contamination may be defined as an episodic occurrence of adverse health effects in humans (or animals that might be consumed by humans) following high exposure to particular chemicals, or instances where episodically high concentrations of chemical hazards were detected in the food chain and traced back to a particular event.
Yushō disease; mass poisoning resulting from rice bran oil contaminated with polychlorinated biphenyls in Kyūshū killed more than 500 humans and 400,000 chickens. 1971, Iraq. Iraq poison grain disaster : A mass poisoning by grain treated with a methylmercury fungicide which was imported to the country as seed and never intended for human ...
Cases of food poisoning began to be reported in the New York State area on October 18, 2012. The CDC eventually concluded this was an example of O157:H7, its code for a strain of E. coli that is noteworthy for seeming to have genes from a different species, shigella, producing an unusual toxin, though not one especially lethal to human beings ...
Human exposure to chemicals, including forever chemicals or PFAS, from food packaging is widespread, according to the study. Experts call it "concerning." Chemicals leaching from food packaging ...
Research projects may range from assessing the effects of toxic pollutants on the environment to evaluating how the human immune system responds to chemical compounds within pharmaceutical drugs. While the basic duties of toxicologists are to determine the effects of chemicals on organisms and their surroundings, specific job duties may vary ...
New tests done by the Environmental Working Group have found 21 oat-based cereals and snack bars popular amongst children to have "troubling levels of glyphosate." The chemical, which is the ...
Food produced on farms whose land was contaminated with toxic “forever chemicals” may pose a risk to human health, according to a new draft report from the Environmental Protection Agency (EPA).
The problem began in 2012, when the process for making tetrazole, a chemical intermediate in the production of various angiotensin II inhibitor medications for hypertension (popularly known by their common drug name suffix "sartan") was changed by generic drug manufacturers in favor of several cheaper and more efficient processes.